Prescription and adherence patterns of antithrombotic therapy for the secondary prevention of stroke in patients with atrial fibrillation

被引：0
|
作者：
Sanchez-Saez, Francisco [1 ]
Riera-Arnau, Judit [2 ]
Hurtado-Navarro, Isabel [1 ]
Rodriguez-Bernal, Clara [1 ]
Sanfelix-Gimeno, Gabriel [1 ]
机构：
[1] FISABIO, Fdn Promot Hlth & Biomed Res Valencia Reg, Valencia, Spain
[2] Autonomous Univ Barcelona, Vall dHebron Univ Hosp, Clin Pharmacol Serv, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2021年 / 77卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
93
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [31] Prevention of Stroke in Patients with Atrial Fibrillation: The Role of New Antiarrhythmic and Antithrombotic Drugs
    Roether, Joachim
    Crijns, Harry
    [J]. CEREBROVASCULAR DISEASES, 2010, 30 (03) : 314 - 322
  • [32] Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation
    Testai, Fernando D.
    Aiyagari, Venkatesh
    [J]. RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2011, 2 : 71 - 81
  • [33] Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation
    Miller, PSJ
    Drummond, MF
    Langkilde, LK
    McMurray, JJV
    Ögren, M
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0C) : C41 - C54
  • [34] Primary and secondary stroke prevention for patients with atrial fibrillation in Latvia
    Jurjans, K.
    Miglane, E.
    Millers, A.
    Priede, Z.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E396 - E397
  • [35] Temporal trends in antithrombotic patterns for stroke prevention in patients with atrial fibrillation and wide spectrum of coronary artery disease
    Hudzik, B.
    Trzeciak, P.
    Desperak, P.
    Desperak, A.
    Gasior, M.
    [J]. EUROPEAN HEART JOURNAL, 2018, 39 : 1005 - 1006
  • [36] Guideline adherence for stroke prevention and risk of mortality in patients with atrial fibrillation
    Chao, T. F.
    Lip, G. Y. H.
    Chen, S. A.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 907 - 908
  • [37] A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
    LaHaye, Stephen Andrew
    Gibbens, Sabra Lynn
    Ball, David Gerald Andrew
    Day, Andrew George
    Olesen, Jonas Bjerring
    Skanes, Allan Cameron
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (17) : 2163 - 2171
  • [38] Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention
    Peterson, GM
    Boom, K
    Jackson, SL
    Vial, JH
    [J]. INTERNAL MEDICINE JOURNAL, 2002, 32 (1-2) : 15 - 23
  • [39] PRESCRIPTION PATTERNS, ADHERENCE AND QUALITY OF MANAGEMENT OF WARFARIN IN CHINESE PATIENTS WITH ATRIAL FIBRILLATION
    Du, Xin
    [J]. HEART, 2013, 99 : E244 - E244
  • [40] Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy
    Stramba-Badiale, Marco
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (07) : 840 - 842
12345